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The objectives of this study were to evaluate the effect of number of stocker cattle in
receiving pens (large: n=150 cattle; small: n=50 cattle) on 1) BRD morbidity/mortality, and
performance, 2) antimicrobial use and prevalence of antimicrobial resistance in Mannheimia
haemolytica, and 3) profitability of stocker operations. No differences were found for morbidity
(p=0.5041). Mortality tended (p=0.0744) to be higher in large groups. BW increased (p<0.0001)
over time. A treatment*day interaction (p=0.00592) was found for ADG, with largest gains for
both groups from day 14-28. M. haemolytica recovery decreased (p=0.0002) over time.
Antimicrobial resistance (p=0.0179) and MDR (p=0.0405) were higher in the small group.
Treatment costs were higher in the small group ($1,093.53/hd) compared to large ($1,037.04/hd).
Because of the nature of a pilot study, further research are needed to determine the effectiveness
of reducing animals in a pen on health, growth, AMR, and profitability associated with stocker
cattle.

DEDICATION
Nana, you are missed more than you can ever imagine. I could not have accomplished
any of this without you looking out for me up in Heaven. I know I was not able to be there as
often as I wanted to, especially moving so far away from home. For two years I was eleven hours
from home and only able to come home for holidays; but it was not until I came six and a half
hours away when your health started deteriorating. I never expected my first semester here at
Mississippi State that you would end up in the hospital, when I would travel home every
weekend for a month and a half to see you regardless of your health. My one regret- the one
weekend I could have come home, the weekend before Thanksgiving, I should have gone home
to see you. I will always thank Dr. Dinh for being so understanding of my situation and letting
me makeup my test after Thanksgiving break so I could go be with you after you passed. I made
you a promise the day of your funeral that I was going to finish my degree, that I did not spend
all this time away from home for nothing, and I told you I was going all the way. I meant every
word, and I hope you were able to carry that note with you as you walked through those pearly
gates. I hope that I am making you proud down here, completing what I told you I was going to
do. I cannot wait to see you again. I love you so much. This is for you.

ii

ACKNOWLEDGEMENTS
To my major professor, Dr. Brandi Karisch, your mentorship and time that you have
given me to do this project has truly opened my eyes to a world of the beef cattle industry that I
was not familiar with. The opportunities and relationships that I have been able to build while
under your wing has given me so much, and I will forever be grateful. To my committee- Dr.
Amelia Woolums, Dr. Josh Maples, and Dr. Trent Smith- the fields that I was able to learn more
of, the disciplines and knowledge that I have gained, and the role models that you are to me,
have opened my eyes in more ways than one. Thank you for being a part of my journey. To each
of you, I am forever grateful.
Thank you to the professors, the graduate students, others who have been there in one
way or another. Here at the end, I gained an incredible support system in my grad student family
that I cannot thank enough. Maggie Loftin, Arminda James, Kate DeShazo, Michelle
Fenstermaker, Allison Harmon- you each will do amazing things in life. I am so blessed to call
you my friends. I would not have been able to complete this project without the help of the farm
crew, William White, Cody Glenn, and Corey White, and my incredible pen riders “Peanut”,
Charlie, Cord, and Jake. Without each of you, I would never have been able to keep the hair on
my head, nor the memories that I have. It will be a time that I will cherish forever. I am
incredibly thankful to Johnny Treichel, Brett Crow, and Tucker Wagner for funneling a love for
livestock judging to me and giving me a chance to prove myself both on the team and as assistant
coach. It was an amazing journey, and I thoroughly enjoyed it all.
iii

This list gets extremely long, but if I did not detail it all I would not be acknowledging
everyone who had a hand in pushing me through. Shannon and Lezlie, my Dad and Mom- thank
you for all of your love and support throughout the many years I have been in school. Every
phone call, motivational speech, and visit made life away from home much easier. It has been so
hard being away for so many things, and your words lifted me to push through. To my brother
Kagen- I look up to you more than you will ever be able to realize. Thank you for always
pushing me to be my better self, and for giving me a hard time when I needed it. Watching you
grow up and being your older sister has been a privilege and a huge roller coaster- one that I will
always want to ride. To Hunter, you have helped me through the past two years more than you
will ever know. You kept me on my toes, you pushed my knowledge on any subject, and have
taught me so much. I will be forever grateful to have you as a friend, a partner, and a mentor. I
will be forever grateful that Brett Crow introduced the two of us, because without you I do not
know how I could have got through this all. Pawpaw and Grandmama- you have always been
there to extend a loving arm when it was needed. I cannot be more thankful for the many days
that I was able to be with you either in the hay field, working cows, or just sitting inside talking.
Aunt Shanda and Uncle Ricky- you have opened your home and your horses to me, let me come
over and enjoy your company over the holidays when I needed it most, gave me a seat in the
truck to go to barrel races and to the racetracks to watch you compete. You have been there more
times than not, and I am so blessed to have you both in my life. To my friends, my “people,”
who were there for a late-night phone call, study session, break down, or anything in betweenKyle Fitch, Allyn Garrett, Carley Greer, Kerrigan Meaux, Amber Coker, Dr. Michael Meaux,
Kim Meaux, Valari Rutherford, Dr. Courtney Heaton, Alicia Gilmore, Sarah Montgomery, Allie
Nestor, Kayla Higgs- thank you for helping me in more ways you will ever know. To those not
iv

mentioned because I have a horrible memory and the list of people is so long, my extended
family in Texas and elsewhere, thank you for being my biggest supporters. You may not be listed
definitively, but you will forever be in my heart.
My time at Mississippi State may be coming to an end, but the memories and the list of
people to thank are too long to even fathom. I have forgotten so many to place here but have not
forgotten what you have done for me personally. Thank you. As always, Hail State and Go
Dawgs!

v

TABLE OF CONTENTS
DEDICATION ................................................................................................................................ ii
ACKNOWLEDGEMENTS ........................................................................................................... iii
LIST OF TABLES ....................................................................................................................... viii
LIST OF FIGURES ....................................................................................................................... ix
NOMENCLATURE ........................................................................................................................x
CHAPTER
I.

INTRODUCTION .............................................................................................................1

II.

LITERATURE REVIEW ..................................................................................................5
Bovine Respiratory Disease ..............................................................................................5
Predisposing Factors for BRD ...........................................................................................6
Mannheimia haemolytica ..................................................................................................7
Antimicrobial Resistance Across BRD Causative Agents ..............................................10
Economic Impact of BRD ...............................................................................................13
Conclusion .......................................................................................................................16

III.

ASSESSMENT OF THE EFFECT OF PEN SIZE ON HEALTH, ANTIMICROBIAL
USE AND RESISTANCE, AND MANAGEMENT-RELATED COSTS IN
STOCKER CATTLE ......................................................................................................18
Objectives ........................................................................................................................18
Materials and Methods ....................................................................................................18
Cattle Handling and Management .............................................................................18
Treatment of Cattle ....................................................................................................20
Bacterial Collection ...................................................................................................20
Cost Analysis .............................................................................................................22
Statistical Analysis ....................................................................................................23
Results and Discussion ....................................................................................................24
Cattle Performance ....................................................................................................24
Number of Treatments Affecting Body Weight and ADG .................................27
Cattle Health ..............................................................................................................28
Fever on Arrival ..................................................................................................28
vi

Morbidity .............................................................................................................29
Mortality ..............................................................................................................31
Mannheimia haemolytica Recovery and Antimicrobial Resistance ..........................31
Economic Analysis.....................................................................................................35
Shared Costs ........................................................................................................35
Differentiated Costs .............................................................................................36
Purchase and Processing................................................................................36
Sell Costs .......................................................................................................37
Fencing Costs ................................................................................................38
Antimicrobial Treatment Costs .....................................................................39
Death Loss .....................................................................................................41
Conclusions .....................................................................................................................43
REFERENCES ..............................................................................................................................54
APPENDIX
A.

BOVINE RESPIRATORY DISEASE SCORING SYSTEM, BACTERIAL
INFECTIONS LIST, AND DESCRIPTION OF ECONOMIC
BREAKDOWN ..........................................................................................64
BRD Scoring System .......................................................................................................65

vii

LIST OF TABLES
Table 3.1

Effect of pen size on body weights of cattle over a 60-day trial ................................46

Table 3.2

Effect of pen size on average daily gain of cattle over a 60-day trial ........................46

Table 3.3

Effect of pen size on days at risk of cattle being assessed for Bovine
Respiratory Disease over a 60-day trial......................................................................46

Table 3.4

Descriptive statistics of the effect of large and small treatment groups on the
costs of inputs and outputs during a 60-day trial ........................................................47

Table A.1 Descriptive statistics for the effect of large and small treatment groups on the
costs of cattle that died during a 60-day trial .............................................................67
Table A.2

Descriptive statistics for the effect of large and small treatment groups on
associated costs for pasture fencing ...........................................................................68

Table A.3 Descriptive statistics for the associated costs of antimicrobials administered
to stocker cattle during a 60-day trial ......................................................................69

viii

LIST OF FIGURES
Figure 3.1 Descriptive statistics for the outbreak curve of stocker cattle that succumbed
to Bovine Respiratory Disease during a 60-day trial..................................................48
Figure 3.2 Effect of pen size on the percentage of stocker cattle shedding Mannheimia
haemolytica during a 60-day trial ...............................................................................49
Figure 3.3 Effect of pen size on percentage recovered Mannheimia haemolytica that
were multidrug resistant during a 60-day trial ...........................................................50
Figure 3.4 Effect of pen size on antimicrobial resistance found antimicrobials for
Mannheimia haemolytica isolates from stocker cattle over a 60-day trial for
days 0, 14, and 60 .......................................................................................................51
Figure 3.5 Prices of bought cattle in Mississippi over a ten-year production period ..................53

ix

NOMENCLATURE
ADG

Average Daily Gain

BW

Body Weight

BRD

Bovine Respiratory Disease

PI

Persistently Infected

AMR

Antimicrobial Resistance

MDR

Multidrug Resistance

BVDV

Bovine Viral Diarrhea Virus

AMP

Ampicillin

CEF

Ceftiofur

PEN

Penicillin

DAN

Danofloxacin

ENRO

Enrofloxacin

GM

Gamithromycin

TDP

Tildipirosin

TIL

Tilmicosin

TUL

Tulathromycin

TET

Tetracycline

SPE

Spectinomycin

FLR

Florfenicol
x

CHAPTER I
INTRODUCTION
The beef production system includes several phases which cattle transition through
during their lifetime, and forage-based systems dominate these phases. However, the nature of
the system exposes cattle to multiple stressors that increase respiratory disease risk. Historically
antimicrobials have been a major tool for controlling BRD, but emergence of antimicrobial
resistance indicates this may not be sustainable. Reducing the number of animals in a pen is a
simple management practice that may impact BRD transmission, and in turn decrease
antimicrobial use and antimicrobial resistance. With some consumers demanding beef raised in
a system with no antimicrobial use, validation of management practices to keep cattle healthy
with less antimicrobial use is vital to improving the productivity, profitability, and sustainability
of beef systems. The effect of pen size on BRD morbidity and antimicrobial resistance in
forage-based stocker cattle has not been investigated.
Ninety percent of U.S. cow-calf operations have fewer than 100 cattle, with these
operations representing 46% of the U.S. beef cow inventory (USDA, NASS 2007 Census of
Agriculture). Calves from cow-calf operations will be utilized for beef after being fed in a
feedlot. Before entering the feedlot, calves are often placed on pastures to allow time for added
growth and immune development. Stockering not only helps calves prepare to efficiently mature
into healthy feedlot cattle, it also provides farmers with a low-overhead source of income based
on seasonal availability of forage (Rankins and Prevatt, 2013; Rhinehart and Poore, 2013; Horn,
1

2006). However, the transportation and commingling inherent in this system predisposes stocker
cattle to bovine respiratory disease (BRD), the leading cause of sickness and death in stocker and
feedlot operations (Sweiger and Nichols, 2010).
Stockering newly weaned cattle has become an important market for the livestock
industry. The stocker industry adds value to cattle by allowing time for building immunity,
improving the nutrition plane of younger cattle, adding growth and weight to lighter calves, and
providing feedlots with a higher quality calf (Peel, 2003). The building of immunity is important
in “high risk” cattle, as the stressors of weaning, environmental changes, and management
practices that have not been performed by producers (i.e. castration, vaccination, deworming)
can affect the immune system. Profitability becomes key for stocker operations, as the
commingling of cattle from unknown origin and managements allows for increased possibility of
morbidity and mortality.
With high-risk, newly weaned stocker calves comes increased problems with diseases
and sickness. Locating and purchasing of cattle in different markets, the ability to optimize on
forages and inputs in pastures and pens, management and facilities, cattle performance, and
ultimately profitability of the operation are all determined by the ability to maintain healthy
cattle (Sweiger and Nichols, 2010). As the risk of morbidity and mortality increases, the cost of
disease control (drug costs) increases, so it is important to keep a strong immune system to
decrease the rate of disease (Edwards, 2010).
Cattle with sickness are typically treated with antimicrobials, which have been widely
used to treat and prevent BRD outbreaks. However, recent reports have shown antimicrobial
resistance among many classes of antimicrobials and bacterial organisms most commonly
associated with BRD cases. Specifically, high levels of resistance have been reported for
2

Mannheimia haemolytica, Pasteurella multocida, and Histophillus somni, in particular
oxytetracycline, tulathromycin, and penicillin (Timsit et al., 2017). Mannheimia haemolytica has
been most associated with BRD in stocker and feedlot cattle (Step et al., 2007; Nickell and
White, 2010). Management practices that ensure stocker health while decreasing reliance on
antimicrobials should improve sustainability of U.S. cattle operations.
Within cattle herds, sickness has been known to travel from animal to animal in a variety
of ways, the most common being nose-to-nose contact. Antimicrobial usage in single animals
has been shown to increase the risk of isolating susceptible and MDR M. haemolytica from pen
mates (Noyes, 2015). It may be possible that reducing the number of animals in a pen could
decrease the incidence of morbidity, antimicrobial use, and antimicrobial resistance. If smaller
stocker cattle groups require less antimicrobial treatment for BRD, producers could have a
validated tool to maintain stocker health and decrease antimicrobial use.
Bovine respiratory disease encompasses a vital portion of economic losses in the beef
cattle industry in both stocker and feedlot operations. In 2015, economic loss from cattle that
succumbed respiratory disease was $907.8 million, or 24.6%, of the total value of nonpredator
death losses in cattle and calves (USDA, 2017). Because of difficulty of collecting data and
records, most of the economic data that is used today comes from feedlot operations.
At the feedlot and backgrounding facility, respiratory disease impacts include mortality
(death loss values), reduce weight gain, reduced feed efficiency, reduced salvage value of
chronic animals, treatment costs, vaccination costs, and metaphylaxis costs (Peel, 2020). Over
the years, the costs of antimicrobial treatments, decreases in performance, and feedlot/stocker
manager’s bottom line have influenced the need for management strategies that reduce
antimicrobial use. Regardless of the situation, improving immune function is key to having a
3

profitable animal, as immunity is the first line of defense when it comes to stocker cattle.
However, it has yet to be discussed whether sorting cattle into smaller pens may reduce the
incidence of respiratory disease. Because of the economic impacts of BRD despite continued
developments in vaccinations and other technologies, this research focuses on the idea that
reducing the number of cattle within a pen may impact the costs of respiratory disease to the
stocker and feedlot operations. This study tests the impact of a simple husbandry practice,
maintaining cattle in small groups, on BRD rates, antimicrobial use, antimicrobial resistance, and
production costs.
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CHAPTER II
LITERATURE REVIEW
Bovine Respiratory Disease
Bovine Respiratory Disease (BRD; also known as shipping fever) is the most costly
disease in North America and is the leading cause of sickness and death in beef cattle (Griffin,
2007; Woolums et al., 2018). Bovine respiratory disease is a multifactorial disease usually
caused by various predisposing factors. It is caused by a variety of pathogens, both viral and
bacterial in addition to stressors that have weakened the immune system. Stressors that could
lead to a weakened immune system can be weaning, changes in feed or nutrition, processing
(castration, vaccination, deworming), and variations in climate (temperature and weather). Also,
the complex generally occurs with viral agents, such as BVDV, being considered as precursors
to, or occurring simultaneously with, bacterial infections (Cusack et al., 2003).
Case definition for diagnosing BRD varies greatly in the literature. General signs for
cattle with BRD include, but are not limited to, an elevated body temperature of ≥40°C, various
respiratory signs (nasal discharge, increased respiratory rate, or cough), anorexia, depression, and
lethargy. Often, cases show a various combination of these signs or other secondary signs of
illness (Taylor et al., 2010). Problems arise with diagnosing BRD, as cattle tend to disguise their
signs from those observing the animals. Lung lesions were reported in 61.9% of cattle observed
at slaughter, while 60.9% of those cattle were never diagnosed and treated for BRD (Schneider et
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al., 2009). This study highlights the true difficulty of identifying disease in cattle that appear
healthy but are suffering from sickness.
Predisposing Factors for BRD
Local auction markets provide an important way for cattlemen to market their cattle.
Performing an analysis of the marketing channels competing for stocker calves, Schmitz et al.
(2003) estimates that roughly 66% of stocker cattle are marketed through public auction, 19%
privately sold, 11% sold through video auction, and 5% marketed through internet sales. Trailers
of low-managed cattle arriving to sale facilities with high-managed cattle, as well as the
commingling among different cattle and stresses of weaning combined make auction barns a
prime location for contracting pathogens. This, in combination with the stress of hauling to a
new environment, suppresses immune function of cattle and allows for greater possibility of
sickness, and the increased risk of contracting respiratory disease.
Depending on the type of management that cow-calf producers have, some weaned cattle
may have never been processed before entering the sale barn. Processing entails vaccinating,
deworming, and castrating the cattle prior to sale at an auction barn. Failing to process newly
weaned cattle exposes them to increased risks for compromised immune system, especially when
added stressors of shipping and commingling are factored in.
Viral agents can cause direct damage to respiratory clearance mechanisms and lung
parenchyma, facilitating translocation of bacteria from the upper respiratory tract to establish
infections in the lung (Taylor et al., 2012). Also, viral infection can interfere with the immune
system’s ability to respond to bacterial infection (Martin et al., 1986; Czuprynski et al., 2004).
Common viral agents accounting for BRD infections include bovine herpesvirus 1 (BHV-1),
6

parainfluenza virus type 3 (PI-3), bovine viral diarrhea virus (BVDV), and bovine respiratory
syncytial virus (BRSV; Cusack et al., 2003). It has been shown that persistent infection (PI) with
BVDV increases BRD occurrence, but it is unclear if PI calves affect other cattle in the feedlot
(Taylor et al., 2010). Vaccinating and reducing the chances for viral agents to infect the animal
could decrease BRD outbreaks and benefit the overall immunity of the herd.
Environmental factors that can affect animal health can include climate, stocking density,
humidity, shipping distance, and ambient temperature (Snowder et al., 2006). Cernicchiaro et al.
(2012) reported that distance travelled was significantly associated with BRD morbidity and
mortality and concluded that knowing distance travelled could allow more precise prediction of
cattle feedlot healthy and performance. Vast differences in weather can change the immune
status of the animal, such as a moderate temperature and cloudy day changing to rain and
freezing temperatures. All of these can affect animal health and possibly compromise the
immune system.
Mannheimia haemolytica
The four bacteria that are most isolated from BRD cases are Mannheimia haemolytica
(M. haemolytica), Pasteurella multocida (P. multocida), Histophillus somni (H. somni), and
Mycoplasma spp. (Griffin, 1998; Fulton et al., 2009). Each bacterium is known to be indigenous
to the nasopharyngeal passages, and, after stress or viral infection, can proliferate and be inhaled
into the lungs (Panciera and Confer, 2010). It has been shown that M. haemolytica is the bacteria
most common BRD bacteria isolated in stocker and feedlot cattle (Fulton et al., 2002; Step et al.,
2007; Nickell and White, 2010; Woolums et al., 2018). Increased use of antimicrobials among
the cattle industry segments has led to an increase in antimicrobial resistance among these
7

different bacteria. The importance of the bacterial organism in terms of colonization,
transmission dynamics to pen mates, antimicrobial resistance, and multidrug resistance, are
major reasons for this research.
M. haemolytica, formally known as Pasteurella haemolytica, is a small gram-negative,
facultatively anaerobic bacterium that expresses weak hemolysis on blood agar plates (sheep or
bovine blood agar plates are typically used). The bacteria are normally indole negative, oxidase
positive, and catalase positive. As well, it is a fermentative, nonmotile, and a non-spore-forming
rod or coccobacillus (Griffin et al., 2010). The genus Mannheimia is part of the class αProteobacteria, order Pasteurellales, family Pasteurellaceae (Griffin et al., 2010). The
Mannheimia genus is differentiated from Pasteurella by the fermentation of mannitol and failure
to use d-mannose (Griffin et al., 2010), along with 16S rRNA sequence phylogeny and DNADNA hybridization (Zecchinon et al., 2005; Griffin et al., 2006). M. haemolytica can be defined
by at least 12 capsular serotypes (1, 2, 5-9,12-14, 16, and 17), with serotype A1 being associated
with >75% of clinical cases (Confer and Step, 2009).
Bacteria are often found in the nasopharynx of healthy cattle but have substantially more
growth in morbid animals. M. haemolytica remains confined in the tonsillar crypts of the upper
respiratory tract, primarily the nasopharynx. When cattle are stressed, the replication rate of the
bacteria increases rapidly. The increased bacterial growth rate in the upper respiratory tract,
followed by inhalation and colonization of the lungs, may occur because of immune suppression
brought on by stressors or a viral infection. During growth in the lungs, virulence factors are
produced. These virulence factors include the capsule, outer membrane proteins, adhesins,
neuraminidase, endotoxin, and exotoxic leukotoxin (Jeyaseelan et al., 2002). The interaction
between the virulence factors and host defenses results in tissue damage, with characteristic
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necrosis, thrombosis, and exudation, leading to the development of pneumonia. Recently, Cozens
et al. (2019) found that the virulence determinants of M. haemolytica serotype A1 facilitate the
invasion of the respiratory epithelial cells allowing for increased replication and spread to nearby
cells where extensive damage to the lung tissues can occur. This, however, was not reported in
other serotypes commensal to the respiratory tract (Cozens et al., 2019).
Nasopharyngeal swabs can be used for determination of colonization in the nasopharynx.
This method of bacterial collection has proven to be quick, simple, and relatively non-invasive.
Nasopharyngeal swabs have been used in varieties of studies to give researchers an idea of
bacteria present and the degree of which bacteria colonization has occurred (Fulton et al., 2002;
Jong et al., 2014; Timsit et al., 2017; Woolums et al., 2018), as well as being the recommended
tool for studying antimicrobial susceptibility (DeRosa et al., 2000). The difficulty with
nasopharyngeal swabs is that the swab may not contact the bacteria that researchers are studying.
As well, bacterial colonies may be in one portion of the nasopharynx, where the swab may not be
able to reach. Pass and Thompson (1971) reported that M. haemolytica were present on the
surface of the nasal epithelium, and that while a bacterial culture revealed that there was no M.
haemolytica isolated from a nasal swab culture it did not mean that M. haemolytica was absent
from the nasopharynx. Similarly, Capik et al. (2015) determined that there were fluctuations in
the pattern of M. haemolytica shedding and the ability to recover M. haemolytica from a culture
swab to show the true representation of bacterial presence in the animal.
Understanding transmission dynamics of M. haemolytica is needed to adapt control
measures during BRD episodes (Miles, 2009). Little information is known about the
transmission dynamics of M. haemolytica. It is not clear whether M. haemolytica associated
BRD cases are due to predisposing factors that enable the resident flora to overcome the cattle’s
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immune system or due the contagious spread of a single virulent clone among pen mates, or due
to both (Rice et al., 2007; Taylor et al., 2010). Timsit et al. (2013) reported that isolation of M.
haemolytica was confirmed on 14/16 BRD episodes, with two to three different clones reported
for ten episodes and only one clone recovered in four episodes. The significant within-pen
diversity of M. haemolytica during BRD episodes indicates that disease is not primarily due to
the spread of a single virulent clone among cattle (Timsit et al., 2013). These reports concluded
that more research needs to be performed on transmission dynamics to enable more coherent
understanding the transfer of M. haemolytica from calf to calf.
Antimicrobial Resistance Across BRD Causative Agents
Historically, antimicrobials have been an effective tool for controlling BRD. Stocker
operations rely on antimicrobials to control disease outbreaks in cattle, overall allowing for
animals to become healthy at a faster rate and decreasing the duration of periods of little to no
growth. The typical administration of antimicrobials can be divided up into three practices,
including 1) prophylaxis, 2) metaphylaxis, and 3) growth promotion (Cameron and McAllister,
2016), with growth promotion no longer allowed in production settings. Unfortunately, these
practices are described very inconsistently in literature. For example, the American Veterinary
Medical Association and US Food and Drug Administration describe prophylaxis and
metaphylaxis as therapeutic, while others may consider these to be sub-therapeutic, nontherapeutic, or production usage (American Veterinary Medical Association, 1998; McEwen and
Fedorka-Cray, 2002; Center for Veterinary Medicine, US Food and Drug Administration).
Today, antimicrobials are typically given either therapeutically for prophylaxis, metaphylaxis, or
for treating diseases. Regardless of the route taken to improve livestock health, bacterial
10

resistance that is acquired in response to antimicrobial usage has damaged future efficacy of
these antimicrobials, due to the AMR genes that are linked in clusters, leading to the multidrug
resistant (MDR) organisms (Cameron and McAllister, 2016). Even with this, the difficulty with
diagnosing how the problem of antimicrobial resistance came to be lies in three main arguments:
1) most antimicrobials are approved for use in multiple food-animal species; 2) off-label nonintended usage of antimicrobials is a common practice worldwide; and 3) the antimicrobial may
not have been administered to the animal (Cameron and McAllister, 2016). Lingering questions
still remain on where the true beginning of antimicrobial resistance lies but the best routes for
controlling the spread of the AMR bacteria are an important topic among research.
Recent reports show high rates of antimicrobial resistance found among bacteria for
multiple antimicrobial classes. Timsit et al. (2017) discovered high levels of resistance to
tulathromycin, oxytetracycline, and penicillin among M. haemolytica, P. multocida, and H.
somni. This brings forth more difficulty in determining practices that reduce the incidence of
BRD among cattle to decrease the prevalence of antimicrobial resistance and multidrug resistant
(MDR) bacteria. Researchers show MDR isolates from lung tissue of fatal BRD cases and
suggest that prevalence of MDR bacteria is increasing. Booker et al. (2008) examined
microbiological and histopathological findings in fatal BRD cases from Canadian feedlots. This
study utilized diagnostic developments, such as immunohistochemical (IHC) staining, and
histopathologic examination to allow for a more sensitive, descriptive collection of data that
previous studies had not utilized prior. Researchers concluded that both Mannheimia
haemolytica and Mycoplasma bovis were the most isolated bacterial organisms, with M.
haemolytica most predominant in peracute, acute, and subacute cases (Booker et al., 2008).
Lubbers and Hazlicek (2013) conducted a retrospective analysis from 2009 to 2011 to determine
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antimicrobial multidrug resistance and coresistance patterns among M. haemolytica isolated from
BRD cases for antimicrobials ceftiofur, enrofloxacin, florfenicol, oxytetracycline,
spectinomycin, and tilmicosin. By 2011, 82.7% of isolates were resistant to at least one
antimicrobial. Further, in 2009 approximately 35% of M. haemolytica isolates were pansusceptible (susceptible to all six antimicrobials tested) with resistance to 1, 2, 3, 4, and 5
antimicrobials being 9%, 15%, 13%, 24%, and 5%, respectively, among M. haemolytica isolates,
while in 2011 there were 17%, 8%, 12%, 3%, 25%, and 35% of recovered isolates resistant to 0,
1, 2, 3, 4, and 5 antimicrobials, respectively (Lubbers and Hazlicek, 2013).
Resistance among different classes of antimicrobials has been noted in recent years,
especially when studying M. haemolytica. Between 2000 and 2009, Portis et al. (2012) reported
overall decreases in susceptibility of M. haemolytica to danofloxacin, tilmicosin, tulathromycin,
enrofloxacin, and florfenicol. High levels of antimicrobial resistance against macrolides
(tulathromycin and tilmicosin) and tetracycline (oxytetracycline) have been reported in many
studies. Similarly, in a three-year retrospective analysis, Lubbers and Hanzlicek (2013)
determined that there were significant coresistance patterns seen in oxytetracycline and
tilmicosin, with bacterial isolates resistant to either antimicrobial more likely to be resistant to at
least one other antimicrobial. Snyder et al. (2017) examined the prevalence of MDR M.
haemolytica isolated from stocker cattle at arrival and two weeks after processing when given
metaphylaxis with tulathromycin. Of the 169 cattle, 27 were culture positive for M. haemolytica
at arrival with 1 MDR strain of M. haemolytica isolated (Snyder et al., 2017). At second
sampling, 366 individual M. haemolytica isolated were collected from the cattle with 361 of
these isolates classifying as either intermediate or resistant to all macrolides tested (tilmicosin,
gamithromycin, and tulathromycin) and the fluoroquinolone enrofloxacin (Snyder et al., 2017).
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The significant increase in minimum inhibitory concentrations (MICs) for M. haemolytica for
tilmicosin and tulathromycin leads to question if the antimicrobials are truly effective treating
BRD, as well whether M. haemolytica could harbor resistance genes for macrolides that could be
transmitted to other respiratory pathogens (Portis et al., 2012; Zaheer et al., 2013).
The transmission of genes amongst bacteria has become a newer topic with research
occurring over the last few years, especially for antimicrobial resistance genes associated with
resistance to antimicrobials used to treat BRD. Integrative conjugative elements (ICE) have been
discovered to transmit resistance genes among BRD pathogens. Integrative conjugative elements
are genetic elements that are part of the bacterial chromosome and can be excised from the
genome and transferred to other adjacent bacterial microbes (Johnson and Grossman, 2015).
ICEMh1 was recently detected in a strain of M. haemolytica that carried resistance to
aminoglycosides, tetracyclines, and sulfonamides, and shares a high degree of similarity with
ICEPmul, encoding eleven resistance genes within two clusters, including tetracyclines,
phenicols, sulfonamides, macrolides, or tilmicosin/tulathromycin (Eidam et al., 2013). Not only
does this raise questions on how these genes can be transmitted amongst bacteria of the same
genus, but also how the genes are transmitted to bacteria of other species and possibly families.
Economic Impact of BRD
The forage-based gains of stocker production are the least expensive and contribute to the
cost competitiveness of the beef industry (Peel, 2003). However, the economic impact of BRD
on the stocker, backgrounder, or feedlot has been found the most economically important health
problem facing these operations (Daniels et al., 1999). Past research indicates BRD associated
costs are $750 million annually (Griffin, 1997), with more recent reports documenting economic
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loss from cattle that succumbed respiratory disease was $907.8 million, or 24.6%, of the total
value of nonpredator death losses in cattle and calves (USDA, 2017). Respiratory disease
remains an extensive and costly problem for the beef industry, with the deaths alone from BRD
associated cases costing over $600 million annually (USDA-APHIS-VS, 2011). When looking
into costs of other inputs such as feed and seed, pasture, fencing, labor, and expenses such as
antimicrobial treatments, cost of animals, and vaccines/dewormers, the performance from the
stocker cattle becomes highly important to the operation’s bottom line.
The National Animal Health Monitoring System’s (NAHMS) Beef Feedlot 2011 study
(2013) reported that approximately 21.2% (2.9 million) of the cattle placed in feedlots were
affected by BRD. The Beef Feedlot 2011 study (2013) reports that the average cost for treating a
single case of BRD in feedlots with a capacity of 1000-7999 head and feedlots with a capacity of
8000 or more head was $23.40 and $23.90, respectively, which has increased significantly from
costs suggested during a similar study in 1999. As well, cost of treatment for the cattle with
acute interstitial pneumonia ($21.70/case) was much higher than the treatment of lameness
($13.40/case) and digestive problems ($9.90/case; USDA-APHIS-VS, 2013). Additionally,
Brooks et al. (2011) found that when combining backgrounding and finishing phases, cattle that
received three or more treatments and cattle defined as “chronics” lost $72.01 and $143.20 more
than cattle that were not treated for BRD. With these figures, the estimated cost for treatment of
2.9 million BRD cases is $54.12 million, not including the production losses due to morbidity
and mortality (Johnson and Pendell, 2017). Net returns for cattle in operations that never
received treatments are significantly higher ($30.08 ± $66.57) compared to cattle that are treated
once or more after diagnosis of BRD (range of $-47.79 ± $82.23 for ≥3 treatments through
$15.84 ± 67.12 for 1 treatment) (Cernicchiaro et al., 2012). A study performed by Wilson et al.
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(2017) also found that when cattle are treated for BRD once, twice, or three or more times, net
returns were decreased by $38, $167, and $230 per calf, respectively.
When cattle are treated with multiple doses of antimicrobials, the cost of treatment for
BRD cases increases. Brooks et al. (2018) found that treatment costs ($/head) will increase from
$0,00, $9.63, $23.62, and $35.71 as the number of treatments increase from 0, 1, 2, and 3
treatments, respectively. Cattle designated as “chronics” (receive all three antimicrobial
therapies according to protocol, on feed more than 21 days, and experienced net loss of body
weight over preceding 21 days on feed) from this study incurred $35.34/head for treatment
(Brooks et al., 2011). The BRD treatment costs from this study were much higher than previous
studies (range of $0.00/head to $21.70/head; Edwards, 1996; Fulton et al., 2002).
Gains from stocker cattle who have been treated for BRD decreases with the number of
treatments given and duration of sickness. A study performed by Snowder et al. (2006)
demonstrated that economic loss associated with lower gains and treatment costs for BRD
infection in a 1000-head feedlot was estimated at $13.90/head, not including labor and handling
costs. Cernicchiaro et al. (2013) reported ADG of cattle with 0, 1, 2, or 3 or more treatments as
1.47 ± 0.28 kg, 1.36 ± 0.23 kg, 1.30 ± 0.21 kg, and 1.24 ± 0.19 kg, respectively. Additionally,
production parameters measured from a wreck pen (denoted as a pen of cattle pulled for BRD
treatment) compared to average metrics for similar cattle had 37.04% death loss (0.7% average),
0.66 lb/d ADG (3.78 lb ADG average), 221 days on feed (166 d average), and feed to gain ratio
of 27.48 (5.88 average; Cernicchiaro et al., 2013). Not only does this further emphasize the
importance of health of the cattle, but the effect on gains and profitability from cattle contracting
BRD is detrimental.
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BRD influences performance of cattle beyond the feeding phases. On the rail, the
carcasses of cattle differ from healthy cattle to those who were sick. Schneider et al. (2009)
reports significant differences in BRD incidence on acclimation ADG, overall ADG, final body
weight (BW), fat, and marbling. Similarly, Cernicchiaro et al. (2012) noted hot carcass weight
(HCW)) decreasing with added number of treatments for each animal with BRD (HCW: zero
treatments= 340.89 ± 38.25 kg, ≥3 treatments= 329.54 ± 42.02 kg), in addition to carcasses
grading choice or better compared to less than choice (zero treatments: ≥choice= 46.82% vs. less
than choice= 53.18%; ≥3 treatments: ≥choice= 27.92% vs. less than choice= 72.08%). Brooks et
al. (2011) provided data supporting that carcass characteristics differ between healthy cattle and
those diagnosed with BRD.
Conclusion
Newly weaned, unprocessed cattle are at the highest risk for immune system weakening,
allowing for sickness to affect the animal. These cattle are typically lightweight with unknown
origin and health status. Cattle with these criteria are considered high risk and
immunocompromised. This situation provides the opportunity for disease spread among cohorts
and the increased likelihood for BRD, the most costly disease in recently weaned calves, despite
improvement in management practices, vaccinations, and antimicrobials (Galyean et al., 1999).
Various predisposing factors can lead to BRD in high-risk cattle. Sale barns are the most
likely destination for cattle coming from cow-calf producers, regardless of management
practices. As well, sale barns can facilitate spread of illness due to multiple stressors such as
commingling, nose-to-nose contact, and recent weaning, which can cause compromised immune
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function. Other factors such as viral infections, processing of cattle, and environmental factors
can also affect the cattle’s immune status.
Bovine respiratory disease is a complex illness that suppresses the ability of cattle to
perform. It has been shown that BRD can have negative consequences on carcass traits,
including carcass weight, ribeye area, and marbling (Thomson and White, 2006; Larson, 2005;
Gardner et al., 1999; Smith, 1998). With several bacteria endogenous to the nasopharynx of
cattle, M. haemolytica is one of the most important bacterial pathogens associated with the
development of BRD and is frequently isolated from the airway of feedlot and stocker cattle with
disease (Fulton et al., 2009; Timsit et al., 2017). Transmission dynamics for this bacterium are
not as well known, thus research studying transmission among cohorts could give some insight.
Antimicrobial resistance to different antimicrobial classes is becoming a problematic
issue in bacteria that contribute to BRD. With resistance being found in many classes of
antimicrobials that have been typically used for treatment of BRD in the past, it is important to
ensure that resistance among bacterial pathogens associated with BRD does not continue to
become more problematic over time. Management practices, such as decreasing pen size to
alleviate the spread of sickness, may have an influence on the growing problem of antimicrobial
resistance.
Profitability is always important to producers and managers of stocker and feedlot
operations. Not only does the cost of cattle influence profitability, but the number of treatments,
labor, land, and gains of animals determine how much return individuals will receive.
Determining the differences among profitability of different pen sizes is an area that has not been
studied, and the goal for this research is to give a baseline for others to continue to study pen size
and the relevance of economic data to producers.
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CHAPTER III
ASSESSMENT OF THE EFFECT OF PEN SIZE ON HEALTH, ANTIMICROBIAL USE
AND RESISTANCE, AND MANAGEMENT-RELATED COSTS
IN STOCKER CATTLE
Objectives
The objectives of this study were: 1) to examine the effect of number of stocker cattle in
a receiving pen on BRD morbidity and mortality and on cattle performance; 2) to examine the
effect of number of stocker cattle in a receiving pen on antimicrobial use and prevalence of
antimicrobial resistance in Mannheimia haemolytica; and 3) to evaluate the economic impact of
receiving pen size on the profitability of stocker cattle operations.
Materials and Methods
All procedures in this study were approved by the Institutional Animal Care and Use
Committee at Mississippi State University (IACUC # 16-604).
Cattle Handling and Management
Due to market constraints at the time the study was conducted, cattle arrived in two loads
and were processed upon arrival. Cattle were individually identified, weighed, sale barn tag
recorded, ear notched for BVDV-PI testing, vaccinated (Ultrabac® 7 (Zoetis Services LLC.,
Parsipanny, NJ) and Express® 5 MLV (Boehringer Ingelheim Animal Health USA Inc., Duluth,
GA), dewormed (Safe-Guard® Dewormer (Merck Animal Health, Madison, NJ)), and a
18

nasopharyngeal swab collected. The first load of cattle (n=103) arrived on day -8. After
processing on day -7, cattle were placed onto pasture with ad libitum hay and grass for 7 days.
Cattle were checked daily for signs of BRD or other illness and any that were treated between
day -7 and 0 were not enrolled in the study. The second load of cattle (n=137) arrived on day -1
and placed in a separate pasture. On day 0, the cattle were processed, nasopharyngeal swab
collected, sorted into pen groups, and moved to pastures. Cattle were placed on rye grass
pastures with ad libitum access to mineral (Bovatec Stocker Mineral, Purina Animal Nutrition,
Arden Hills, MN). Pen riders trained in identifying BRD signs assessed each pen and evaluated
cattle based on clinical signs of BRD, including, but not limited to, depression, anorexia, rapid
respiratory rate, cough, or nasal discharge. If cattle were regarded as potential cases, rectal
temperature, BRD score (Appendix A), and treatment were recorded. Cattle were returned to
pasture after completion of treatment according to standard protocol. All cattle were observed for
60 days for BRD, bloat, footrot, pinkeye, and other diseases that could affect stocker cattle. All
pulls and treatments were recorded on treatment record sheets. If an animal sustained an injury or
developed a disease not included in the protocol, a veterinarian was called to examine each case
and determine the course of action. All cattle that died were taken to CVM Diagnostic
Laboratory and submitted for gross necropsy, lung tissue was submitted for aerobic culture and
antimicrobial susceptibility testing for cattle with lung pathology consistent with BRD.
Cattle were weighed on day 14, 28,42, and 60. Cattle in each pen were removed
individually and did not come into physical contact with other treatment groups on sampling
days. Samples were collected and cattle were moved back to the original pasture.
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Treatment of Cattle
Treatment for BRD followed a 3-drug regimen (administered in series according to
persistence of clinical signs). The first treatment was ceftiofur crystalline-free acid (Excede,
Zoetis Services LLC., Parsipanny, NJ) administered as a single subcutaneous injection (SC) in
the posterior aspect of the ear where it attaches to the head (base of the ear) to cattle at a dose of
6.6 mg ceftiofur equivalents (CE) body weight (BW). Cattle were assigned a post-treatment
interval (PTI) of 7 days during which no additional treatments for BRD were allowed. Cattle
which met the criteria for treatment 8 days or longer after ceftiofur treatment were treated with
florfenicol (Nuflor, Merck Animal Health, Madison, NJ) by a single SC injection in the neck at a
dose of 40 mg/kg body weight. After florfenicol treatment, cattle were assigned a PTI of 3 days.
Cattle which met the criteria for treatment 4 days or longer after florfenicol treatment were
treated with oxytetracycline (Noromycin 300 LA, Norbrook Inc., Overland Park, KS) by a SC
injection in the neck at a dose of 20 mg/kg. No further treatments were administered to cattle
with signs of BRD after a third treatment. During the PTI following any treatment, or after the
third treatment, cattle with a BRD score of 3 or 4 were examined by a veterinarian to determine
whether euthanasia was warranted.
Bacterial Collection
A nasopharyngeal swab was collected from each animal using a 60 cm long guarded
swab (Double Guarded Culture Swab, #022964, MWI, Nampa, ID, USA) as previously
described (Woolums et al., 2018). Swabs were then transferred into Amie’s transport media
(Modified Amies Clear Gel, SP130X, Starplex Scientific Inc. Etobicoke, Ontario, Canada).
Nasopharyngeal swabs were collected from all cattle upon arrival and on days 14 and 60. All
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nasopharyngeal swabs were transported to the Mississippi State University Veterinary
Diagnostic Center. Within 8 hours of collection, swabs were streaked onto a sheep’s blood agar
plate via quarter streaking method and placed in an incubator at 37°C plus 5% CO2. At 24 and
48 hours after incubation, the plates were assessed for colonies with morphology typical of M.
haemolytica. If more than one colony with typical morphology were found, one bacterial colony
was selected using indole, oxidase, and catalase testing to confirm the colony was likely M.
haemolytica (indole negative, oxidase and catalase positive). Colonies with consistent
morphology and positive tests were subcultured onto a sheep’s blood agar plate and incubated
for 24 hours. If only one typical colony was identified on the primary plate, the colony was
subcultured onto a new blood agar plate and indole, oxidase, and catalase testing was conducted
on a colony selected after 24 hours of subculture. Pure cultures obtained on the subcultured plate
were transferred to 50% glycerol solution and stored at - 80°C until the end of the trial, when all
isolates were submitted to the Diagnostic Bacteriology Laboratory at Mississippi State
University for antimicrobial susceptibility testing via the TREK Diagnostics Sensititre™ System
(TREK, ThermoFisher Scientific Inc.). M. haemolytica isolates were defined as resistant to one,
two, or three or more antimicrobial classes. Isolates were considered resistant to a class if they
displayed resistance to one or more antimicrobials within that class that also had Clinical
Laboratory and Standards Institute (CLSI) breakpoints for M. haemolytica in BRD. M.
haemolytica isolates were defined as multidrug resistant (MDR) if they were resistant to three or
more antimicrobial classes. Antimicrobials considered with established breakpoints for BRD as
defined by the CLSI were ampicillin, ceftiofur, penicillin, danofloxacin, enrofloxacin,
florfenicol, gamithromycin, tildipirosin, tilmicosin, tulathromycin, tetracycline, and
spectinomycin.
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Cost Analysis
Economic impact of pen size was estimated between large and small pen sizes.
Production records for cattle were obtained from arrival to sale date to determine general
profitability between pens. Records utilized in the analysis were purchase price, pasture costs,
antimicrobial costs, labor, vaccines, mineral, fencing, and selling price.
Treatment groups shared incurred expenses and income for the trial in purchase costs,
labor, facility use, water, seed planter, and sale of cattle. Differences in costs between treatment
groups were calculated for pasture costs (includes fencing, ryegrass seed/ha, fertilizer/ha, seed
used/ha, and tank usage), total costs for antimicrobial treatments, tagging equipment,
vaccinations, and death loss. Total cost for treatment was calculated by adding each of the costs
(pasture costs, antimicrobial treatment costs, tagging equipment, vaccinations, and death loss)
and cost for treatment group/animal was calculated.
For this study, retailers that were commercially available to producers were used to
determine pasture costs for both treatments, with recommendations from Wheeler Metals
(Muskogee, OK) for materials used for corner posts and braces for fencing, seed and fertilizer
purchased from local farming co-operative (Oktibbeha County CO-OP) in Starkville, MS,
previous purchases for stock tanks and other water supplies from past purchases, and Tractor
Supply for all other supplies.
Fencing costs were determined with actual dimensions of pastures which cattle were
located for the trial, with measurements for perimeter of pastures, number of gates, feet of barbed
wire used for five-strand fence, corners, pasture splits, and t-post spacing were all considered.
Fertilizer and seed used were calculated on the hectares for each of the respective pastures based
upon the total dimensions of the pastures which cattle were located. Total pasture costs for the
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large and small treatments were calculated by adding fencing costs, water materials costs, and
fertilizer and seed costs. Costs per hectare was determined by taking the total cost per treatment
divided by the number of hectares allotted for each treatment.
Antimicrobial treatment costs were determined by using online website. Each
antimicrobial used (Excede (ceftiofur), Nuflor (florfenicol), and LA 300 (oxytetracycline))
offered different sized bottles containing either 100, 250, 300, or 500 ml of antimicrobial
treatment. Calculations for antimicrobial treatments for each size bottle were calculated based
upon the milliliters utilized for each of the treatments in the study and were based on the size of
bottle utilized during the study.
Death loss was determined as the cost of calf at time of purchase added to the cost of the
calf until it died. The cost of the calf at time of purchase was determined as the expected
purchase weight (3% of arrival body weight + arrival body weight) multiplied by the purchase
cost. Cost until dead was determined by the cost per hectare per day multiplied by the amount of
days between the start of the project and when the calf died. Treatment costs were included in the
treatment analysis and were not included in death loss figures.
Statistical Analysis
All analyses were performed in SAS 9.4 (SAS Inst., Inc., Cary, NC). Response variables
included morbidity, mortality, DAR, BW, ADG, M. haemolytica recovery, resistance to
approved antimicrobials for BRD treatment in M. haemolytica, and MDR M. haemolytica. Fixed
effects were treatment (large and small treatment groups), with covariates included in the health
and performance models being fever on arrival, and covariates included in the bacterial
resistance analyses being fever on arrival and health status (whether animal was treated or not).
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For performance and recovery data, main effects of treatment and day, and treatment*day
interactions were reported. For all analyses, subject was arrival date nested within treatment,
random effect included individual pen that animals were housed within treatments, and pen was
the experimental unit. A Fisher’s Exact test was used to evaluate significance of covariates
within the respective models. Economic data were recorded.
Morbidity, mortality, and DAR were assessed using the GLIMMIX procedure of SAS 9.4
using the Laplace method. Body weights and average daily gain was assessed using the MIXED
procedure of SAS 9.4 testing for interactions and main effects, with repeated variable as day and
differences adjusted with the Tukey method. Recovery of M. haemolytica, antimicrobial
resistance, and MDR M. haemolytica were assessed using the MIXED procedure of SAS 9.4.
Susceptibilities to antimicrobial classes were determined according to CLSI breakpoints.
Susceptibilities for antimicrobials used to control BRD with established breakpoints for M.
haemolytica included ampicillin, ceftiofur, penicillin, danofloxacin, enrofloxacin, florfenicol,
gamithromycin, tildipirosin, tilmicosin, tulathromycin, tetracycline, and spectinomycin were
described for each bacterium recovered.
Statistical significance was set at p ≤ 0.05, with tendencies reported at 0.05 < p ≥ 0.1.
Results and Discussion
Cattle Performance
Results for body weight (BW) can be found in Table 4.1. Results for ADG are reported in
Table 4.2 for ADG d 1 to 14, 14 to 28, 28 to 42, and 42 to 60. There was no treatment by day
interaction for BW (p = 0.4708) and no main effect of treatment (p = 0.5577). However, there
was a main effect for day (p < 0.001), with body weights continuing to increase for each
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sampling period for both treatment groups. There was a tendency for a treatment by day
interaction for average daily gain (p = 0.0592). On each of the respective sampling days, there
were no differences in ADG between the large and small treatment groups. Gains for cattle in
both the large and small treatment group were the highest from days 14-28 (large=1.30 ± 0.13
kg/d; small= 1.17 ± 0.14 kg/d). The poorest ADG was within the small treatment groups from
days 0-14, gaining 0.19±0.14 kg/d. The lowest ADG for the large treatment group was seen
during days 42-60 with cattle gaining 0.27 ± 0.13 kg/d.
Increases in body weights can be expected from growing cattle in any feeding situation.
Currently, there are several studies that have evaluated the effect of different numbers of animals
within groups on various outcomes, but not within stocker or feedlot realms. A study performed
by Gottardo et al. (2005) compared three groups of veal calves based on the number of animals
in each group (3, 5, and 7 head) with the same space allowed per head and found that the number
of calves per pen did not affect gain, intake, or feed efficiency. Similarly, with this stocker study
there was the same amount of space per calf (0.02 ha/head of cattle), and there was no difference
for BW or ADG between the two treatments on specific sampling dates. Also, a study with
chickens found that stocking rate had no effect on performance parameters of broiler chickens
and concluded that high yield per unit could still be achieved at smaller or larger stocking
densities (Turkyilmaz, 2008). Based on these two studies and the findings from this pen size
study, it is still possible to achieve a similar weight gain and ADG regardless of the number of
head placed on pastures while allowing similar hectares per head.
However, a study focusing on the number of ewes and lambs carried at different stocking
rates found that ewe live weights and lamb weaning weights decreased as stocking rates
increased but noted that the larger number of animals carried at higher stocking rates
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outperformed animals in smaller groups and resulted in more kilograms of lamb weaned per
hectare regardless of poorer performance of each lamb (Sharrow et al., 1981). Although the
study focused on performance of sheep at different stocking rates, it also assessed pasture
performance at different stocking rates. At the conclusion of this research, pastures stocked with
9.9 ewes/ha were producing 10 to 12% more forage than those stocked at 7.4 and 12.4 ewes/ha
(Sharrow et al., 1981). From this study, researchers suggests that there is a minimum as well as a
maximum stocking rate that needs to be established to maximize forage production. Similar to
this group size study with stocker cattle, the quality of forage was not assessed, but this current
study did not assess whether the pastures cattle were housed in produced more forage based on
treatment group. Based upon these findings, further studies could be replicated based off of these
types of research at the same and larger levels (more pens per treatment, more differences in
number of animals in a pen) to determine the true impact of BRD on the performance of cattle in
differing stocking densities, to assess maximum sustained forage production and quality, and
determine how quality of forage can affect cattle that are or are not treated for BRD.
While this stocker study did not discuss social behavior, it has been shown to influence
multiple aspects of livestock production, from smaller animals such as fish to cattle. Jorgensen et
al. (1993) found that growth rates among fish that were stocked at medium and high densities
were similar yet were markedly depressed compared to fish stocked at the lowest stocking
densities. The authors determined that social constraints due to the formation of dominance
hierarchies may not have been the prime reason for appetite and growth reduction seen in groups
stocked at high densities (Jorgensen et al., 1993). A study performed to assess the influence of
different stocking densities on weight gain and behavior on feedlot lambs found that average
weight gain was higher for individually penned animals compared to animals found in collective
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pens, and that the number of animals per group influenced the behavior of confined lambs, which
changed the pattern of food intake which could improve weight gain (da Cunha Leme et al.,
2013). A study on feeder lambs found that the feeding system for groups of lambs had an effect
on growth rates, live-weight at slaughter, carcass weights, dressing percentage, and fat thickness,
as well as carcass confirmation scores and fat degree (Carrasco et al., 2009). While these studies
are not focusing on stocker production, there has yet to be much research discussing behavior of
cattle in larger and smaller groups, and how this may possibly affect performance, social
behavior, and grazing activity.
Number of Treatments Affecting Body Weight and ADG
The number of antimicrobial treatments given to cattle throughout the trial influenced
BW (p < 0.0001). Cattle receiving no antimicrobial treatments gained 15.8 kg and 46.8 kg more
than cattle receiving one (p < 0.0001) and two or more (p < 0.0001) antimicrobial treatments,
respectively. Also, cattle receiving one antimicrobial treatment gained 31.1 kg more than cattle
receiving two or more antimicrobial treatments (p < 0.0001). Average daily gain was also
influenced by the number of antimicrobial treatments given to cattle (p = 0.0021). Cattle
receiving no antimicrobial treatment trended to gain more than cattle treated once with
antimicrobials (0.70 kg/d ± 0.07 vs. 0.58 kg/d ± 0.08; p = 0.0698) and gained more than cattle
receiving two or more antimicrobials (0.70 kg/d ± 0.07 vs. 0.21 kg/d ± 0.16; p = 0.0014).
Additionally, cattle receiving one antimicrobial treatment gained 0.36 kg/d more than cattle
treated two or more times with antimicrobials (p = 0.0208).
There is extensive research showing the effects of BRD on performance of cattle.
Hubbard et al. (2018) found that ADG of cattle diagnosed with BRD were 0.15 lb/day lower than
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cattle undiagnosed with BRD. These authors also found that calves with BRD gained an average
64.1 lb less than unaffected calves over the stocker phase (Hubbard et al., 2018). In another
study, feeder cattle and cattle treated for BRD had a mean ADG reduction of 0.07 kg/d, which
could result in 3-7% daily reduction in performance (Thompson et al., 2006; Theurer et al.,
2015a, 2015b). These studies, like this stocker study, show that cattle not treated with
antimicrobials are more likely to experience more weight gains in respect to both BW and ADG
compared to cattle treated for sickness. Different management strategies have been studied to
reduce the impacts of BRD on animal performance, from vaccinations against viral and bacterial
agents (Martin et al., 1982; Richeson and Falkner, 2020), deworming strategies (Wagner, 2018),
preconditioning (Step et al., 2008; Cole, 1985), and administering metaphylaxis on arrival, to
name a few, which have showed promise in decreasing the impacts of BRD related sickness in
cattle.
Cattle Health
Fever on Arrival
The median rectal temperature for cattle upon arrival was 39.3°C (102.8°F), with the
range 38.1°C-41°C (100.6°F-106.3°F). Elevated temperatures of 40°C (104°F) or greater were
noted in 17 of 200 cattle. Fever on arrival had an effect on BRD morbidity and mortality, as
cattle arriving with a fever were more likely to be treated for BRD (p=0.0163), but less likely to
die (p=0.0242). Out of the 17 cattle that arrived with fever, 58.82% (n=10) were treated for
BRD. In contrast, out of the 183 cattle that arrived without a fever, 19.43% (n=55) contracted
BRD during the trial. Of the 17 cattle with a fever on arrival, 18% (n=3) died from BRD.
Contrastingly, 82% (n=14) cattle died from BRD that did not arrive with a fever.
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Similar to this study, Griffin et al. (2018) found that cattle with high fever at arrival had
increased BRD morbidity but is not reported among literature why cattle arriving with a fever
were less likely to die. The threshold at which fever is defined, however, does vary among
literature. For instance, this study as well as Griffin et al. (2018), Woolums et al. (2018), Wagner
et al. (2018), Jelinski and Janzen (2019) et al. defined fever as 40°C or higher. However, others
defined thresholds for fever ranging from 39.4°C to 39.7°C (Burfeind et al., 2012) or diagnose
BRD cases based upon outward signs of BRD rather than fever. Similarly, most stocker or
feedlot operations diagnose BRD based upon outward signs. Finding ways to identify a common
temperature to define fever, as well as a standard BRD scoring system for identifying cases, is
needed to standardize a method that can be used by all.
Morbidity
Results of DAR can be found in Table 3.3. There were no differences between large and
small treatment groups for morbidity (p=0.5041) or incidence density (p=0.8397). Overall
morbidity totaled 32.5% (65/200), with 34% and 28% of cattle in large and small treatment
groups treated for BRD. From day 0 to 7, the greatest number of cattle (n=41) exhibited clinical
signs of BRD and were treated, with 48 cattle treated once and 2 cattle receiving a second
treatment before day 14. Of the 65 cattle that were treated once, 12 cattle were treated a second
time with florfenicol. Out of the 12 cattle that received the second treatment, 5 cattle were treated
a third time with oxytetracycline. Incidence density was calculated at 7.28 BRD cases/1,000 calf
days, with 8,698 total days at risk being reported.
Respiratory diseases are the leading cause for sickness in feedlot cattle within the United
States (Edwards, 2010; Sanderson et al., 2008; Wilson et al., 2017), Australia (Cusack, 2004),
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Canada (Church and Radostits, 1981; Smith, 1998), and Brazil (Malafaia et al., 2016; Baptista et
al., 2017). The Beef Cattle Research Council describes that BRD accounts for 65-80% of the
morbidity seen in some feedlots. A West Texas A&M Study also noted that typically morbidity
ranges from 20 to 80%, with an average morbidity of 35% (Richeson, 2018). Also, a Brazilian
study found that when all sick feedlot cattle were considered (n=13,315 head), BRD was
determined to be the principal cause of morbid cases, accounting for 86.9% of all sickness
(Baptista et al., 2017). Similarly, a separate Brazilian review assessing mortality cases in feedlots
from 2000 to 2017 found that aside from acidosis, the most common disease associated with
feedlot deaths was pneumonia (Silva et al., 2020). None of these studies previously mentioned,
however, were performed to assess the number of animals in a pen, but rather on a typical feedlot
setting. However, this study does fall within the typical morbidity range, relating closely to the
average morbidity seen in feedlot cattle of 35% (Richeson, 2018).
Most (n=48) of the BRD cases seen with this study were within the first two weeks of the
study, slowly declining to about 1-4 BRD cases and then seeing a slight increase in BRD cases
around day 42 with no cases diagnosed and treated after. Richeson (2018) discussed that over
90% of the BRD cases occur before day 42 in high-risk cattle that were received in the West
Texas A&M Research Feedlot. While it is not uncommon to have BRD cases typically outside of
7-21 days after receiving, there are many factors that could have affected the pattern of BRD
cases seen in this study, such as commingling of the two groups and additional stress of pulling
sick cattle from the pens.
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Mortality
Mortality tended to be different between large and small treatments (p=0.0744). Overall
mortality totaled 5.5%, with all deaths occurring in the large treatment group. Two out of the five
cattle receiving all three antimicrobial treatments died during the trial. Out of the eleven cattle
that died, four were humanely euthanized. Ten of the cattle that died had bacterial organisms
recovered from the lung tissue upon necropsy, with only one that had no bacterial growth
recovered. None of the bacterial organisms recovered from the necropsies were M. haemolytica.
All cattle that died suffered from bronchopneumonia.
In 2006, respiratory disease accounted for 28.7% of all deaths in stocker and feedlot
operations (USDA, 2006). Dubrovsky et al. (2019) found mortality attributed to BRD in their
study of preweaned dairy calves was 19.3%, with a range of 0 to 27.1%. Richeson (2018)
reported an average 5% mortality within stocker and feedlot operations. Additionally, Brazilian
feedlots found that BRD was the major cause of mortality among their cattle (Baptista et al.,
2017). A 5.5% mortality rate was observed in this study with all deaths were occurring in the
large treatment group. These results suggest that the large pen size possibly increased the risk for
mortality, which could be due to increased commingling within the large treatment group.
However, given the limitation of the small number of pens, the study should be repeated with a
larger number of pens in each treatment to confirm this effect.
Mannheimia haemolytica Recovery and Antimicrobial Resistance
Results for recovery of M. haemolytica can be found in Figure 3.2. Results for MDR M.
haemolytica can be found in Figure 3.3. Discussion of resistance profiles for individual
antimicrobials can be found in Figure 3.4. There was no treatment*day interaction (p=0.4953)
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for recovery of M. haemolytica isolates from cattle. However, there is a main effect of day
(p=0.0002) as recovery of M. haemolytica was higher on day 0 (p < 0.0001) and 14 (p = 0.189)
compared to day 60, with no difference between recovery on day 0 compared to 14 (p = 0.3209).
There tended to be a main effect of treatment (p=0.0873), as the large treatment group tended to
have more recovery of M. haemolytica than the small treatment group. There was no
treatment*day interaction (p=0.2863) or main effect of day (p=0.5854) for resistance patterns of
M. haemolytica isolates, but there was a main effect of treatment (p=0.0179) as there was greater
instances of antimicrobial resistance found in the small treatment group compared to the large
treatment group. There was no treatment*day interaction (p=0.4562) or main effect of day
(p=0.6955) for MDR M. haemolytica. However, there was a main effect of treatment (p=0.0405),
as MDR M. haemolytica were more commonly isolated in the small treatment group compared to
large treatment group. There were no differences in resistance to individual antimicrobials
among bacterial isolates from healthy cattle and cattle treated for BRD within treatment groups.
Resistance to tetracycline was most common, with 16/43 (37%), 14/34 (41%), and 3/8 (38%) M.
haemolytica isolates demonstrating resistance on days 0, 14, and 60. Recovered bacteria
exhibited the least resistance to ampicillin. A M. haemolytica isolated on day 14 from one calf in
the large group that had been treated once for BRD demonstrated resistance to ceftiofur.
Out of 200, 192, and 189 cattle on trial on days 0, 14, and 60, 127, 109, and 67 bacterial
isolates were confirmed M. haemolytica isolates. Recovery rates of M. haemolytica were 43/127
(34%), 34/109 (31%), and 8/67 (12%), respectively, with M. haemolytica prevalence decreasing
over time. On day 0, 34/43 M. haemolytica isolates were recovered from cattle in the large
treatment group. Six of the 43 M. haemolytica recovered on day 0 were MDR, with 4 bacteria
recovered from cattle randomly assigned to the large treatment group. In the small treatment
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group, 9/43 bacteria were recovered with 2 bacteria exhibiting MDR on arrival. On day 14, 34
M. haemolytica were recovered, with 29 from large treatment group and 5 recovered from the
small treatment group. Six bacteria recovered on day 14 and identified as MDR, with 4
recovered from the large treatment and 2 recovered from the small treatment. Eight M.
haemolytica were isolated form cattle on day 60, with 6 isolated from the large group and 2
isolated from the small group. Only 1 MDR bacterial isolate was recovered on day 60 and this
was one of the 2 M. haemolytica isolated from the small treatment group.
Over the sampling period, overall M. haemolytica prevalence decreased. While the
prevalence of cattle shedding M. haemolytica in commingled, recently transported groups
typically increases over the 2 weeks after arrival (Woolums et al., 2018), in this study a subset of
the cattle were received a week before the rest of the cattle. While the day 0 sample was
collected at arrival from cattle in both groups, the day 14 sample was collected 21 days after
arrival in the first subset. Thus, the peak of M. haemolytica shedding could have occurred before
the day 14 samples were collected in those cattle, decreasing the overall prevalence at study day
14. However, the decrease in prevalence could have been due to other bacterial species
overgrowing M. haemolytica. For example, E. coli EC93 uses contact-dependent growth
inhibition to inhibit other bacterial species from growing in population (Ruhe, 2013).
Additionally, Bavananthasivam et al. (2012) found that P. multocida inhibits the growth of M.
haemolytica by contact- or proximity-dependent mechanisms. Magwood et al. (1969) reported
that M. haemolytica was isolated irregularly, even when swabbing both the right and left sides of
the anterior and posterior nasal meatuses of calves multiple times a day for several days in a row.
Timsit et al. (2017) determined that a high proportion of cattle harbored BRD pathogens in the
lower airways when the pathogens were not present in the nasal pathogens. Even with knowing
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how other bacteria affect isolation rates of M. haemolytica and the irregularity associated with
differing nasal passages, these points were not within the scope of this experiment. This should
warrant further studies into determining the bacterial populations within the nasopharynx of
cattle housed within differing group sizes, as well as testing both nasal meatuses of cattle to
determine differences in bacterial populations.
Snyder et al. (2017) found few (10.1%, 8/79) MDR M. haemolytica isolates in cattle
sampled by nasopharyngeal swabs at arrival, but 7-10 days later at second sampling high
prevalence of resistance was identified (99.2%, 363/366), primarily in macrolide class. Timsit et
al. (2017) described high levels of resistance (>70%) against tulathromycin and oxytetracycline
in M. haemolytica and P. multocida isolates. In this study, there was an increase in prevalence of
MDR M. haemolytica in cattle in the small pen group compared to the large pen group. Perhaps
smaller groups of cattle allowed for increased chances of transmission of bacterial isolates
harboring resistance genes among cattle.
Similar to Snyder et al. (2017), in previous work Woolums et al. (2018) identified a high
prevalence (86%) MDR M. haemolytica shedding in a single group of 50 high risk stocker cattle
at 14 days after arrival. The difference in the percent of cattle shedding MDR M. haemolytica at
day 14 between that study and the present study (86% versus 3%) is noteworthy. The difference
may have been related to the fact that cattle in the previous study were metaphylactically treated
with a long-acting macrolide (tildipirosin) at arrival, while the cattle in the present study did not
receive metaphylaxis. Additionally, a 3-day PTI was used in the previous study, while a 7-day
PTI was used for ceftiofur, and a 4-day PTI was used for florfenicol, in the present study.
Research directly comparing the prevalence of MDR bacterial shedding in cattle receiving or not

34

receiving metaphylaxis, and in cattle treated with antimicrobials following different PTI, will be
necessary to confirm the relationship between these practices and MDR prevalence.
Economic Analysis
All analyses for economic data can be found in Table 3.4, with a more detailed
description in Table A.4.
Shared Costs
Labor from d 0 to d 60 for four student workers totaled 618.48 hours at $8.25/hour, with
a total payout of $5,102.46. Cost per day averaged $85.04/day for all workers. Facilities were
utilized for five sampling points over the 60-day trial. Total costs for the facilities used were
$1,851.32, with an average cost per workday (n=5) totaling $106.40. Water used totaled $12.00
for the entirety of the trial.
Both treatment groups had the same number of water tanks (n=3) and totaled $1,343.07
in costs. The large treatment group encompassed 30.36 ha, while the small treatment group had
10.1 ha. Fertilizer costs were $281.05, with the large and small treatment groups incurring
$8,532.68 and $2,838.61 in fertilizer expenses, respectively. Ryegrass seed costs were
$104.51/ha, with the large and small treatment groups totaling $3,172.95 and $1,055.56,
respectively. Total fertilizer and seed costs were $11,705.63 for the large treatment and
$3,894.16 for the small treatment, with $385.56/ha spent on both sets of pastures.
For this study, labor and sale cost were not divided between treatment groups. When pen
riders completed daily checks of cattle, total hours for each day were totaled and calculated at the
end of the trial. Because of the utilization of four observers throughout the trial, pairs of pen
riders rode through either large or small treatments, alternating daily which pens were rode
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through, to ensure that pen riders were getting views of all cattle. Therefore, the total labor costs
were not split between groups. Future studies are warranted to determine the split costs for each
treatment group by using specific individuals for each treatment and one individual recording the
times for checks and pulls.
Differentiated Costs
Purchase and Processing
Cattle were purchased at $1.5797 per pound, a total cost of $195,945.99. The large
treatment group incurred a total purchase cost of $128,164.33 for 150 steer calves. The average
purchase price for the large treatment group was $854.43, with a range of $737.07 - $990.90. the
small treatment group had a total purchase cost of $42,839.68. The average purchase price for
the small treatment group was $856.79, with a range of $737.07 - $964.86.
A total of sixteen packs of tags were purchased for the cattle before processing.
Numbered tags were $26.99/bag, and blank-colored tags were $22.95/bag, each bag holding 25
tags each. A total of $299.64 was incurred for tags in the large treatment group, with 6 bags
purchased of both numbered and blank tags, while the small treatment group had $99.88 worth
of tags purchased, with 2 bags of each tag used. Costs for Ultrabac 7 and Express 5 were $28.39
(250 ml/50 doses) and $113.99 (50 doses). Treatment costs for the large (n=3 bottles) and small
(n=1 bottle) treatment groups for vaccinations totaled $85.17 and $28.39 for Ultrabac 7, and
$341.97 and $113.99 for Express 5, respectively. Safeguard dewormer (1 gallon) was used,
totaling $195 for large treatment costs and $65 for small treatment costs. In total, processing
costs for the large and small treatments were $921.78 and $307.26, respectively, with costs at
$6.15/head to process.
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Cattle prices are influenced by many factors, including changes in cattle slaughter,
supplies of other meat and poultry products, demands for cattle for feeding or grazing, and
consumer demands (Schulz, 2015), as well as other factors such as a processing facility fire and
facility shutdowns. Purchase costs vary depending on the month that cattle are planned to be
purchased. This can be demonstrated in Figure 3.5, where the prices of cattle purchased in
Mississippi are tabled over a ten-year production period. Cattle purchased during the spring
months, typically March-May, are more likely to bring more at an auction market compared to
cattle sold during the fall months, typically August-October. Texas A&M Extension reports that
there may be a seasonal consumer demand pattern that cause livestock producers to alter their
production patterns to take advantage of market opportunities, such as a fewer number of calves
sold during the spring causing an increased demand and price for cattle during these seasons
(Davis et al., 2021). The fluctuations in the cattle market are notable during the seasons, but
ultimately the differences among producer preferences for calving and times to sell cattle are
dependent on each individual producer.
Sell Costs
The total shared expenses that were incurred during the trial was $204,389.13. Cattle
were sold in three different groups at an average weight of 706.67 pounds. Group 1 (n=74 head)
sold at $158.00/cwt, group 2 (n=61) sold at $132.00/cwt, and group 3 (n=68) sold at
$137.00/cwt. After commission, the sale of cattle totaled $197,896.82. The average sell cost for
cattle was $974.86/head. In the large treatment group, 139 cattle were sold in May with a total
income of $135,505.70. In the small treatment group, 50 cattle were sold with a total income of
$48,743.06.
37

Cattle were weighed as a group upon sale, which is typical in a stocker/backgrounding
facility shipping cattle to a feedlot. While the study concluded in March, cattle were sold in May
and the weights from each group divided by the total number of animals were used to calculate
average weight for the individuals within the respective group. Weights for cattle at the end of
the trial were calculated, but not used in the economic analysis. To obtain a price for income
between treatment groups, the total number of head that were sold in May was multiplied by the
average cost for the cattle that were sold. Because of this, further studies could be used to
determine economic evaluation of cattle upon completion of the project.
Fencing Costs
The large treatment incurred a total of $13,927.65 in fencing costs, and small treatment
had $11,165.67 in fencing costs. Four fabricated T-braces ($209.31/brace), seven corner posts
($190.00/corner post), and fifteen H-braces ($125.00/brace) were used for the large treatment
pastures, with $4,042.24 spent on these supplies. A total of eight fabricated T-braces, four corner
posts, and six H-braces were used to create pastures for the small treatment group, totaling
$3,184.48. A total of 1086 and 771 studded T-posts (7 ft, 1.25 lb/ft; $5.22/post) were used for the
large and small treatment groups, with 43 and 31 rolls of barbed wire (1320 ft/roll, 12.5 gauge;
$74.99/roll) used for a five-strand barbed wire fence and one extra bag of T-post clips (50/pack;
$4.99/pack) purchased. Total costs for the five-strand barbed wire fence were $8,89.48 for the
large treatment group pastures and $6,354.30 for the small treatment group pastures. Incurred
costs per hectare for the large and small treatments were $458.75/ha and $1,105.51/ha,
respectively. Costs per hectare per day for the large and small treatment groups were $7.65/ha/d
and $18.43/ha/d, respectively.
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The most noted difference in price occurs when purchasing gates and braces for the small
treatment group, which in turn increases the cost per hectare. For each pasture that the cattle
were housed in, there were two gates. This would increase the number of gates purchased for the
small treatment group to 10 gates compared to only 6 gates needed for the large treatment group.
Additionally, there was a substantial increase for braces needed by the small treatment groups,
particularly for the fabricated T-braces (one H-brace, one pipe cap, and 4 pipe; custom weld).
There was 8 fabricated T-braces needed for the small treatment compared to only 4 needed for
the large treatment. This doubled the costs for the fabricated braces for the small treatment,
showing that the small treatment group would be more cost intensive on a per hectare basis
compared to the large treatment group at a similar stocking density.
Antimicrobial Treatment Costs
During the trial, 51 cattle from the large treatment and 14 cattle from the small treatment
were treated at least once. A total of 417 ml and 90 ml of ceftiofur, 366 ml and 30 ml of
florfenicol, and 84 ml and 0 ml were given to cattle in the large and small treatment groups,
respectively. Bottle sizes for ceftiofur, florfenicol, and oxytetracycline used during the trial were
100 ml, 100 ml, and 250 ml. with costs per bottle at $234.99, $80.71, and $47.99, respectively.
Costs per ml for ceftiofur, florfenicol, and oxytetracycline totaled $2.35/ml, $0.81/ml, and
$0.19/ml, respectively. Total costs/ml for large and small treatments were $979.91/ml and
$211.49/ml for ceftiofur, $295.40/ml and $24.21/ml for florfenicol, and $16.12/ml and $0/ml for
oxytetracycline, respectively. Total costs/bottle of antimicrobial for the large and small treatment
groups were $1,174.95 (n=5 bottles) and $234.99 (n=1 bottle) for ceftiofur, $322.84 (n=4
bottles) and $80.71 (n=1 bottle) for florfenicol, and $47.99 (n=1 bottle) and $47.99 (n=1 bottle)
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of oxytetracycline, respectively. Costs of antimicrobial treatment on a per head basis for large
and small treatment groups respectively was $9.41/head and $15.11/head for ceftiofur,
$26.21/head and $24.21/head for florfenicol, and $3.22/head and $0/head for oxytetracycline,
respectively. Total antimicrobial treatment costs for the large and small treatment groups on a
per head basis was $39.48/head and $39.32/head, respectively.
Losses from respiratory disease among stocker and feedlot operations accounts for 55%
of nonpredator related death loss in cattle and 36% among calves, with a value of $274.84
million in economic losses (USDA, 2017). Antimicrobial treatment costs for stocker and feedlot
operations have been increasing through the years. The USDA NAHMS health and health
management report (2013) shows that feedlots spend approximately $75 million annually on
antimicrobial treatments for cattle, which can be broken down to 16% of cattle in feedlots with
over 1000 head capacity incurring antimicrobial costs of $23.60 for each BRD case. This report
noted an increase in antimicrobial costs from 1999 to 2011, describing those costs over the
twelve-year period increased from $12.59/head to $23.60/head, and suggested that the costs may
increase as time progressed. Even though there were no significant differences among treatment
groups for BRD occurrence, it can be noticed that the cost of antimicrobial treatment on a per
head basis has increased based on the results from the USDA NAHMS report and the conclusion
of this research. Based on the USDA NAHMS findings at the feedlot level, the low amount of
research on economic impact at the stocker level, and the similarities in antimicrobial treatment
protocols between stocker and feedlot operations, it can be concluded that an increase in
antimicrobial treatment costs has been noted in the growing phase from 2011 to 2019. Because
of this, it can be expected that economic costs of antimicrobial treatments will continue increase
with time.
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Another recent study assessed the cost effect of three policies in feedlots: 1) using
antimicrobials for disease prevention, control, and treatment; 2) using antimicrobials only for
treatment of disease; and 3) not using antimicrobials for any reason (Lhermie et al., 2020). This
research determined that when modelling a typical U.S. feedlot, the median net revenue loss with
moderate disease incidence was $66 and $96 per animal entering the feedlot, for not using
antimicrobials to prevent and control diseases, or not using any antimicrobials, respectively
(Lhermie et al., 2020). Lhermie et al. (2020) also reported that in the case of no antimicrobial
use, this decreased feeder price by 9%, which in turn increased the slaughter cattle price by
6.3%, offsetting the net revenue losses for the feedlot operation. However, the question still
returns to whether this practice could be used in an industry perspective. Even though the costs
of not treating cattle with antimicrobials are essentially curbed, the thought comes forth of how
not treating animals is affecting gains associated with the cattle as well as the health of the cattle
going into slaughter, raising concerns for animal welfare and quality of the product going to the
rail. Further, a more detailed analysis of inputs and outputs for usage and prohibition of
antimicrobials to stocker and feedlot cattle will be needed to assess the effectiveness of this
strategy.
Death Loss
Eleven cattle died during the project, all within the large treatment group. No death losses
were incurred for the small treatment groups. Purchase cost of cattle that died ranged from
$802.16 to $956.73, with an average purchase cost of calf at $865.46. Cattle died within day 3
and 53 of the trial (either natural death or humanely euthanized), with an average date recorded
for 18 days on trial. Cattle averaged a purchase weight of 547.9 lbs, with a purchase cost of
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$1.5797/lb. When including only fencing costs, dead cattle averaged $999.61/head in losses,
with a range of $848.03 to $1,269.21 in losses recorded. Total losses from each of the eleven
cattle that died from the large treatment group totaled $10,995.76 when including fencing costs
alone, denoting fertilizer and seed costs as shared costs and not included in this analysis. When
including all pasture costs (fencing, fertilizer, and seed costs), dead cattle averaged
$1,125.31/head in losses, with a range of $891.02 to $1,648.92 in losses recorded. Total losses
from each of the eleven cattle that died from the large treatment group totaled $12,378.44 when
including fencing, fertilizer, and seed costs.
BRD incidence typically occurs from approximately day 7 to 21 after arrival to a
backgrounding facility, but it is not uncommon to have deaths or cattle requiring treatments
outside of this date range. Two cattle that were euthanized on days 35 and 53, with one calf
dying on day 31. The time these three cattle lasting on the trial did increase the average cost until
the animal died and total loss figures. On the other hand, there were cattle that died before day 7
of the trial. However, it is important to note that there was no statistical significance of arrival
time affecting BRD incidence.
In a study performed by Blakebrough-Hall et al. in 2020, the average net loss from cattle
that died was $1,647.53. In this study, the average costs from BRD related deaths were
$1,125.31/head. While losses were lower in this study compared to Blakebrough-Hall et al.
(2020), the calculated figures in this study did not include vaccinations, deworming, tagging, or
antimicrobial treatment costs, so it is possible that the death loss figures incurred in this study
with those figures would be higher and likely compare similarly to the Blakebrough-Hall study.
Hunsaker (2020) assessed the economics associated with calf grower operations in the dairy
industry to determine that for each 1.0% decrease in mortality, an increase of $14.45/head could
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be expected. Authors also noted that at a 10% mortality, a margin of $79.63 exists that can be
reinvested, and $7.42 exists at 15% mortality (Hunsaker, 2020).
This research investigating two different group numbers showed that mortality tended to
be influenced greater in the larger treatment group compared to the smaller treatment group,
enhancing the possibility for smaller groups of cattle to have less sick and dead animals
compared to larger groups. With the additional costs associated with cattle that die in stocker and
feedlot operations, including antimicrobial costs, feed, labor, and other inputs, ways to mitigate
death loss are needed. While it can be expected for losses to be incurred at these operations,
managing these ill animals on a more individual basis or within smaller pens could be the answer
to managing these losses.
Conclusions
Cattle within both large and small treatment groups performed similarly at each of the
sampling periods, with the highest ADGs reported at day 14-28 for both groups. Additionally,
body weights for cattle continued to increase over time, which remained similar with other
research among stocker and feedlot operations as well as in production settings. Still, the weight
that is lost during the first two weeks and possibly later in the trial (if external factors,
introduction of more cattle, or other stress-inducing conditions occur) could be mitigated by
managing the cattle more efficiently. This could be done by reducing the number of animals
within a pen, however, because this is a pilot study with such few numbers, those conclusions
cannot be defined at this time.
How to keep a healthy immune system in cattle will always be an important factor when
discussing ways to mitigate sickness. Better management of cattle prior to auction could possibly
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produce a healthier calf moving forward through the stocker and feedlot phases. However, there
has yet to be any published research within this field, so looking more deeply into managing
cattle upon arrival to reduce the impact of stress could be the answer to decreasing the impacts of
BRD. While there were no differences in morbidity of cattle among treatments, fever on arrival
played an important role in BRD instance, further detailing how important managing cattle prior
to sale can be. Additionally, with more chance for external stressors such as pulling stress,
commingling stress, and herd hierarchy, there is a possibility for larger groups of cattle
increasing the likelihood for more deaths. However, because this tended to be different between
groups, it cannot be concluded that smaller groups of cattle are the answer to decreasing the
amount of dead cattle and several more replicates should be performed to test this difference.
Cattle shedding M. haemolytica was much higher earlier in the stocker period,
highlighting the majority of illness occurring in this trial was during the first two weeks.
Additionally, antimicrobial resistance and multidrug resistant M. haemolytica were more
commonly isolated from cattle in smaller groups. This could be due to the greater chance for
nose-to-nose contact among smaller groups, allowing for more transmission of bacteria
harboring resistance genes. Genotyping was not performed with this study to determine
similarities among bacterial populations isolated from pen mates, which could be an addition for
future studies that will further define the impacts of cattle group sizes.
Expenses associated with stocker cattle show to be greater than the income received at
the end of the stocker phase. Antimicrobial treatment costs alone have increased substantially
over time, accounting for $39-40/head in this stud compared to past figures of $14-21/head.
Based on this research, elevated costs for fencing for the small treatment group and death losses
remaining isolated to the large treatment group influenced the increased costs per head for each.
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Specifically for the small treatment group, there were more materials needed to fence five
separate pastures, with more gates and braces, compared to the large treatment group fencing
three pastures. This increase in price drove the cost per head for fencing higher for the small
treatment group, as smaller pasture sizes are more intensive and cost more per hectare. However,
the big difference lies within the loss for deaths, as all the deaths occurring in the large group
added $10,995.76 ($12,378.44 including fencing, fertilizer, and seed costs) of losses where no
death loss occurred in the small treatment group. Because of this offset, the total loss expected
per head for the large treatment group was less than the small treatment group. When it comes to
economics and the various factors that can affect losses and income for the year, more replicates
for this type of study are needed to be able to determine more finite costs for producers.
Because of the nature of a pilot study, financial reasons, as well as other natural means
that influence morbidity and performance, statistical significance was not reported for all
parameters of interest. However, due to the persistence of BRD and the impacts that it has on the
stocker and feedlot operations, further studies are warranted to determine management strategies
that can reduce BRD incidence. Because of the novelty of pen size to stocker cattle research and
the lower numbers in this pilot study, replications of this research are needed to improve the
power of the study and determine if the number of animals in a pen impacts BRD, performance,
antimicrobial resistance.
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Table 3.1

Effect of pen size on body weights of cattle over a 60-day trial
Item

Large3

2

Treatment1
SEM
Small4

SEM

Body weight, kg
Initial
232.6 a
3.2
232.4 a
d 14
236.6 b
3.2
235.2 b
d 28
255.0 c
3.2
251.8 c
d 42
266.9 d
3.2
260.9 d
Final
270.8 e
3.2
269.0 e
1
Subscripts that differ are considered different (a, b, c, d, e, f, g, h).
2
Body weights were collected every 14 days during the trial.
3
Large: n=150 head of cattle over 3 pens (50 head/pen)
4
Small: n=50 head of cattle over 5 pens (10 head/pen)
Table 3.2

3.5
3.5
3.5
3.5
3.5

Effect of pen size on average daily gain of cattle over a 60-day trial
Item

Treatment1
SEM
Small4

Large3

SEM

2

Average daily gain, kg/d
d 0 to 14
0.17f
.13
0.14h
d 14 to 28
1.20a
.13
1.13ab
d 28 to 42
0.73c
.13
0.59cd
d 42 to 60
0.16g
.13
0.52e
1
Subscripts that differ are considered different (a, b, c, d, e, f, g, h).
2
Average daily gains were calculated at each weight sampling period.
3
Large: n=150 head of cattle over 3 pens (50 head/pen)
4
Small: n=50 head of cattle over 5 pens (10 head/pen)
Table 3.3

.17
.17
.17
.17

Effect of pen size on days at risk of cattle being assessed for Bovine Respiratory
Disease over a 60-day trial

Treatment
lDAR
Large1
2.86
2
Small
3.02
P – value = 0.4387
1
Large: n=150 head of cattle over 3 pens (50 head/pen)
2
Small: n=50 head of cattle over 5 pens (10 head/pen)
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SEM
0.14
0.23

Table 3.4

Descriptive statistics of the effect of large and small treatment groups on the costs
of inputs and outputs during a 60-day trial

Expenses and Income

Shared

Shared
Fertilizer and Seed (cost/hectare)

$385.56

Labor1
Facility use2
Water3
Water Troughs
Total Shared Costs

$5,762.46
$106.40
$12.00
$1,343.07
$6,563.93

Total Shared Income4

$197,896.82

Cost per Treatment Group
Purchase
Total Antimicrobial Treatment
Total Fencing Costs
Total Processing
Death Loss5
Total Cost for Treatments
Total Cost for Treatments/head

Large (n=150) Small (n=50)

$128,164.33
$1,545.78
$13,927.65
$921.78
$12,704.27
$156,937.98
$1,046.25

$42,839.68
$363.69
$11,165.67
$307.26
$ --$54,676.30
$1,093.53

Total Income for Treatment Groups
$135,505.70
$48,743.06
Total of 4 student workers, n=698.48 total hours worked
2
Five working days with an average cost per day of $21.28
3
Contractual water payments billed quarterly
4
Total of 203 cattle sold in two truck loads
5
All deaths were associated with the large treatment group (Pen 1 n=4; Pen 2 n=1; Pen 3 n=6)
1
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Figure 3.1

Descriptive statistics for the outbreak curve of stocker cattle that succumbed to
Bovine Respiratory Disease during a 60-day trial

48

Figure 3.2

Effect of pen size on the percentage of stocker cattle shedding Mannheimia
haemolytica during a 60-day trial

Subscripts that differ are considered different (a, b, c)
Day 0: Large = 30/150; Small = 9/50
Day 14: Large = 29/142; Small = 5/50
Day 60: Large = 6/139; Small = 2/50
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Figure 3.3

Effect of pen size on percentage recovered Mannheimia haemolytica that were
multidrug resistant during a 60-day trial

Subscripts that differ are considered different (a, b)
Large treatment: day 0 = 4/34 MDR; day 14 = 4/29 MDR; day 60 = 0/6 MDR
Small treatment: day 0 = 2/9 MDR; day 14 = 2/5 MDR; day 60 = 1/2 MDR
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Figure 3.4

Effect of pen size on antimicrobial resistance found antimicrobials for Mannheimia haemolytica isolates from stocker
cattle over a 60-day trial for days 0, 14, and 60
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Figure 3.44 (continued)
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Figure 3.5

Prices of bought cattle in Mississippi over a ten-year production period
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APPENDIX A
BOVINE RESPIRATORY DISEASE SCORING SYSTEM, BACTERIAL INFECTIONS LIST,
AND DESCRIPTION OF ECONOMIC BREAKDOWN
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BRD Scoring System
0= Normal
1= Mild BRD including one or more of the following signs:
•
•
•
•

elevated respiratory rate for the environmental conditions
mild to moderate gauntness
mild depressed attitude: not as alert as expected when viewed from a distance becomes
alert when animal sees human observer
shallow or dry cough

Cattle with a score of 1 may also have cloudy, white, or yellow nasal discharge.
Nasal discharge in the absence of any other abnormalities is not enough for a score of 1.

2 = Moderate BRD including one or more of the following signs:
• mild or moderate depression
o lethargic, but may look alert when approached
o head carriage lower than normal, but returns to normal when approached
o hiding behavior: tends to stay behind other cattle, relative to the observer
• mild to moderate muscle weakness
o stepping slowly when walking, or mild incoordination
o droopy ears
• repeated coughing
• moderate gauntness
• breathing with mild to moderately increased abdominal effort
Cattle with a score of 2 may also have:
elevated respiratory rate for environmental conditions
clear, cloudy, white, or yellow nasal discharge.

3 = Severe BRD including one or more of the following signs:
• severe depression or weakness
o lethargic and does not look more alert when approached
o low head carriage, does not return to normal when approached
o does not move away from examiner as expected when approached
o cross stepping
• Repeated deep cough
• Severe breathing effort
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o open mouth breathing or panting
o moderately to markedly increased abdominal effort
Cattle with a score of 3 may also have:
elevated respiratory rate for the environmental conditions
clear, cloudy, white, or yellow nasal discharge
and/or moderate to extreme gauntness.

4 = Moribund (near death)
• recumbent and does not rise when approached or directly stimulated
OR
•
•

standing but does not move unless directly stimulated
o if the animal moves, it is very weak: drags feet, sways, stumbles, falls down
eyes may be very sunken, abdomen may be very gaunt

Moribund animals may also have signs described for score of 1, 2, or 3.
Coughing may be heard from animals with any score.
NOTE: sometimes animals near death may act aggressively, trying to charge an observer
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Table A.1

Descriptive statistics for the effect of large and small treatment groups on the
costs of cattle that died during a 60-day trial

Treatment Animal ID Arrival Temp1 NmTX2
Cause3
Organism4
Large
147
40.3
1
Bronchopneumonia
H. somni
Large
155
38.7
2
Bronchopneumonia
H. somni
Large
170
39.7
1
Bronchopneumonia
P. multocida
Large
172
39.2
2
Bronchopneumonia
M. bovis
Large
175
38.7
1
Bronchopneumonia
T. pyogenese
Large
252
39.4
3
Bronchopneumonia
P. multocida
Large
274
39.2
2
Bronchopneumonia
H. somni
Large
308
40.8
1
Bronchopneumonia
NA
Large
330
41.3
1
Bronchopneumonia
P. multocida
Large
33
39.8
1
Bronchopneumonia
H. somni
Large
338
39.4
3
Bronchopneumonia
H. somni
1
Arrival Temp= rectal temperature at arrival in Celsius
2
NmTx= number of treatments that cattle received throughout project until death
3
Cause= cause of death; each calf that died succumbed death from a type of bronchopneumonia
(ex. acute, suppurative, chronic, locally extensive, severe)
4
Organism= causative organism that infected the lung tissue of dead calf
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Table A.2

Descriptive statistics for the effect of large and small treatment groups on associated costs for pasture fencing

Materials
Item

$22.75
$14.95
$159.99
$74.99
$4.99
$5.22

Quantity
Large
3
3
3
6
43
1
1086

Small
3
3
3
10
31
1
771

Large
$1,229.97
$68.25
$44.85
$959.94
$3,224.57
$4.99
$5,668.92

Small
$1,229.97
$68.25
$44.85
$1,599.90
$2,324.69
$4.99
$4,024.62

$125.00
$190.00
$209.31
$26.99
$281.05
$104.51

15
7
4
1
30.36 ha
30.36 ha

6
4
8
1
10.1 ha
10.1 ha

$1,875.00
$1,330.00
$837.24
$26.99
$8,532.68
$3,172.95

$750.00
$760.00
$1,674.48
$26.99
$2,838.61
$1,055.56

Cost

Tarter Round Plasic Stock Tank, 8'x2', 625 gal
Heavy Duty Alluminum Float, Standard 6"x12" Float
Wide Side Mount Kit- Fits Over 2" Lip
Tater Painted 2 in Tube Gate, 10 ft
OK Brand Premium Barbed Wire, 12.5 guage, 4 pt, 1320'
Chicago Heights Steel Tpost Clips, pack of 50
Studded T-Post, 7 ft, 1.25 lb per foot, includes 5 clips/post, bulk
discount-buy 400 get 5% off per post (5.49 original)
H-Brace, 3 1/2, Wheeler Metals
Corner Post Adjustable- 3 1/2, Wheeler Metals
Fabricated T Brace (H brace, cap, 4 pipe), Wheeler Metals
SpeeCo Deluxe Post Driver, Tractor Supply
Fertilizer, PC Oktibbeha County CO-OP ($11,373.63/40.4686 ha)
Ryegrass seed, Oktibbeha County CO-OP ($4,271.21/40.8686 ha)

$ 409.99

Total Cost for Treatments
Hectares
Total Hectares per Treatment
Cost per head
Cost per hectare per day
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$26,976.35
10.12
30.36
$53.31
$14.81

$16,402.90
2.02
10.1
$162.40
$27.07

Table A.3

Descriptive statistics for the associated costs of antimicrobials administered to
stocker cattle during a 60-day trial

Antimicrobial

Mg/ml

$/bottle

$/ml

Excede
Nuflor
LA 300

200/100
300/100
300/250

$234.99
$80.71
$47.99

$2.35
$0.81
$0.19

Treatment
Large ($/ml)
$979.91
$295.40
$16.12

Table A.3 (continued)
Bottles Used
Large
Small
5
1
4
1
1
1

Total $ Bottle
Large
Small
$1,174.95
$234.99
$322.84
$80.71
$47.99
$47.99
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Group
Small ($/ml)
$211.49
$24.21
$ ----

